Aclaris Therapeutics, Inc. (ACRS)
4.39
-0.02
(-0.45%)
USD |
NASDAQ |
Oct 02, 16:00
4.395
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Price : 4.39 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.44 | 4.52 | 4.205 | 4.39 | 6.209M |
| Oct 01, 2026 | 5.18 | 5.18 | 4.35 | 4.41 | 5.177M |
| Sep 30, 2026 | 5.30 | 5.395 | 5.21 | 5.26 | 2.263M |
| Sep 29, 2026 | 5.42 | 5.45 | 5.155 | 5.28 | 2.052M |
| Sep 28, 2026 | 5.07 | 5.465 | 5.02 | 5.43 | 2.429M |
| Sep 25, 2026 | 5.39 | 5.538 | 5.095 | 5.15 | 1.474M |
| Sep 24, 2026 | 5.24 | 5.44 | 5.145 | 5.38 | 2.489M |
| Sep 23, 2026 | 5.70 | 5.74 | 5.035 | 5.26 | 1.963M |
| Sep 22, 2026 | 5.63 | 5.765 | 5.50 | 5.72 | 2.879M |
| Sep 21, 2026 | 5.55 | 5.62 | 5.40 | 5.57 | 1.521M |
| Sep 18, 2026 | 5.41 | 5.535 | 5.36 | 5.50 | 4.688M |
| Sep 17, 2026 | 5.37 | 5.625 | 5.34 | 5.40 | 3.823M |
| Sep 16, 2026 | 5.54 | 5.56 | 4.975 | 5.32 | 5.772M |
| Sep 15, 2026 | 5.60 | 5.62 | 5.405 | 5.525 | 1.331M |
| Sep 14, 2026 | 5.29 | 5.715 | 5.29 | 5.64 | 5.838M |
| Sep 11, 2026 | 5.50 | 5.595 | 5.17 | 5.32 | 3.278M |
| Sep 10, 2026 | 5.55 | 5.555 | 5.385 | 5.505 | 2.211M |
| Sep 09, 2026 | 6.075 | 6.075 | 5.41 | 5.56 | 3.679M |
| Sep 08, 2026 | 6.08 | 6.145 | 5.915 | 6.06 | 3.061M |
| Sep 04, 2026 | 5.965 | 6.195 | 5.87 | 6.17 | 1.747M |
| Sep 03, 2026 | 6.24 | 6.27 | 5.895 | 5.95 | 1.392M |
| Sep 02, 2026 | 6.09 | 6.24 | 5.875 | 6.18 | 1.550M |
| Sep 01, 2026 | 6.09 | 6.24 | 5.95 | 6.02 | 1.487M |
| Aug 31, 2026 | 5.97 | 6.06 | 5.845 | 6.05 | 1.633M |
| Aug 28, 2026 | 6.10 | 6.18 | 5.95 | 6.01 | 1.221M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 116.23 |
| Xeris Biopharma Holdings, Inc. | 9.08 |
| Alumis, Inc. | 6.85 |
| ANI Pharmaceuticals, Inc. | 72.18 |
| Veru, Inc. | 2.51 |
Price Related Metrics
| PS Ratio | 69.01 |
| Price to Book Value | 4.927 |
| Earnings Yield | -13.33% |
| Market Cap | 613.83M |